Survival Outcomes of an Early Intervention Smoking Cessation Treatment After a Cancer Diagnosis

Authors:

Top Cited Papers
Open Access
Abstract
Smoking by patients with cancer and cancer survivors causes adverse cancer treatment outcomes.1 The 2014 Surgeon General’s report on tobacco reviewed more than 400 studies between 1992 and 2012, concluding that smoking at or following a cancer diagnosis increases both all-cause and cancer-specific mortality, as well as risk for disease progression and tobacco-related second primary cancers. Across various cancer types, continuing to smoke increased the risk of overall mortality by a median rate of 50% and cancer-related mortality by a median rate of 61%. The adverse effects of smoking on cancer treatment outcomes and costs are observed across cancer disease types.2 The 2020 Surgeon General’s report and recent meta-analyses among patients with lung or head and neck cancer support improved survival with quitting smoking among these patients.3-5 However, a significant limitation noted by these reviews was the lack of clear, consistent smoking data and prospective longitudinal outcomes. Importantly, none of these earlier studies analyzed the association of time between diagnosis and entry into a smoking cessation treatment program with survival.

This publication has 32 references indexed in Scilit: